Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-12

FDA Approved: DEXLANSOPRAZOLE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's generic version of Dexlansoprazole via an Original Application (ANDA 219115). The approval adds a generic option …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

ORIG AP for DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)